# Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV with Hemophilia.

> **NCT04688034** · PHASE1 · COMPLETED · sponsor: **Kiminori Kimura, MD** · enrollment: 5 (actual)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **DRUG:** OP-724

## Key facts

- **NCT ID:** NCT04688034
- **Lead sponsor:** Kiminori Kimura, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-15
- **Primary completion:** 2022-07-05
- **Final completion:** 2022-07-05
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2024-10-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04688034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04688034, "Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV with Hemophilia.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04688034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*